Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Carbonate
Patent
1994-10-20
1999-01-26
Pak, John
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Carbonate
424489, 424601, 424605, 424606, 5142388, 514255, 514553, 514561, 514578, 514579, 514669, 514826, 514851, 514951, A61K 914, A61K 3113, A61K 3300, A61K 3342
Patent
active
058635637
ABSTRACT:
Methods and compositions for the treatment of the symptoms of a patient who has a pulmonary condition associated with an inhibition of surfactant secretion by type II alveolar cells are described. The method of treatment involves causing a patient to inhale an amount of a pH-raising buffer effective to raise the pH of the aqueous fluid in the microenvironment of the type II alveolar cell lumenal surface, thereby inducing an increase in the rate of surfactant secretion by type II alveolar cells.
REFERENCES:
patent: 2905589 (1959-09-01), Miller
patent: 4326416 (1982-04-01), Fredberg
patent: 4534343 (1985-08-01), Nowacki et al.
patent: 4592348 (1986-06-01), Waters, IV et al.
patent: 4667668 (1987-05-01), Wetterlin
patent: 4814161 (1989-03-01), Jinks et al.
patent: 4852561 (1989-08-01), Sperry
patent: 4969473 (1990-11-01), Bothwell
patent: 5230884 (1993-07-01), Evans et al.
patent: 5279823 (1994-01-01), Frenz et al.
Chander, A., "Regulation of lung surfactant secretion by intracellular pH," American Journal of Physiology, vol. 257, No. 6, part 1 of 3 parts, pp. L354-L360, 1989.
Ruy V. Lourenco, MD et al., "Clinical Aerosols, II. Therapeutic Aerosols," Arch Intern Med, 142: 2299-2308, Dec. 1982.
John R. Riordan et al., "Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA," Science 245:1066-1072, Sep. 8, 1989.
Bat-Sheva Karem et al., "Identification of the Cystic Fibrosis Gene: Genetic Analysis," Science 245:1073-1080, Sep. 8, 1989.
K. Kunzelmann et al., "Bicarbonate permeability of epithelial chloride channels," Pflugers Arch. Europ. J. of Physiology, 417, 6/616-621, Feb. 1991.
Jeffrey J. Smith et al., "cAMP Stimulates Bicarbonate Secretion across Normal, but Not cystic Fibrosis Airway Epithelia," J. Clin. Invest. 89:1148-1153, Apr. 1992.
Carole M. Liedtke, "Electrolyte transport in the epithelium of pulmonary segments of normal and cystic fibrosis lung," FASEB 6, 12:3076-3084, Sep. 1992.
Georges Saumon et al., "Electrolyte and fluid transport across the mature alveolar epithelium," Journal of Applied Physiology 74, 1:1-15, Jan. 1993.
George A. Scheele et al., "Role of the GP2/THP Family of GPI-Anchored Proteins in Membrane Trafficking During Regulated Exocrine Secretion," Pancreas 9, 2:139-149, 1994.
Henry J. Fuchs, M.D., "Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis," The New England Journal of Medicine 331, 10:637-642, Sep. 8, 1994.
Pamela B. Davis, M.D., Ph.D., The New England Journal of Medicine 331, 10:672-673, Sep. 8, 1994.
Henrik Verder, M.D. et al., "Surfactant Therapy and Nasal Continuous Positive Airway Pressure for Newborns with Respiratory Distress Syndrome," The New England Journal of Medicine 331, 16:1051-1055, Oct. 20, 1994.
P. B'hend et al., "Stimulation of Pancreatic Secretion in Man by Secretin Snuff," The Lancet, I, 7802, 509-510, Mar. 10, 1973.
D. Kaiser et al., "Diminished Excretion of Bicarbonate from the Single Sweat Gland of Patients with Cystic Fibrosis of the Pancrease," Europ. J. Clin. Invest. 4, 261-265 (1974).
P. R. Durie et al., "Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis," Gut, 778-786, 1980.
Poulsen, Jorgen H. et al., "Bicarbonate conductance and pH regulatory capability of cystic fibrosis transmembrane conductance regulator," Proceedings of the National Academy of Sciences, vol. 91(12), pp. 5340-5344, Jun. 7, 1994.
Lubman, Richard L. et al., "Regulation of intracellular pH in alveolar epithelial cells," Am. J. Physiology, vol. 262(1), part 1 of 2 parts, pp. L1-L14 Jan. 1992.
Medline Abstract 92125483 Jan. 1992.
Bosse, George M., "Nebulized sodium bicarbonate in the treatment of chlorine gas inhalation," Clinical Toxicology, Vo. 32(3), pp. 233-241 1994.
Medline Abstract 94275911, 1994.
Solopov, V.N. et al., "Expectoration Disturbances and Bronchial Obstruction," Respiration, vol. 58(5-6), pp. 287-293, 1991.
Medline Abstract 92:125282, 1991.
Scheele, George A. et al., "Pancreatic dysfunction in Cystic fibrosis occurs as a result of impairments in luminal pH, apical trafficking of zymogen granule membranes, and solubilization of secretory enzymes," Pancreas, vol. 12(1), pp. 1-9, 1991.
Medline Abstract 89:130568, 1988.
Solopov, V.N. et al., "Endobronchial therapy in chronic bronchitis patients," Klin. Med., vol. 66(7), pp. 33-36, 1988.
James Baggott, Textbook of Biochemistry with Clinical Correlations 1039-1041 and 1049-1052 (Thomas M. Devlin ed., 1992).
Griffiths and Simons, The trans Golgi Network: Sorting at the Exit Site of the Golgi Complex, Science 234:438-443, 1986.
Davoust et al., Two Threshold Values of Low pH Block Endocytosis at Different Stages, The EMBO Journal 6:3601-3609, 1987.
Ayala, Transport and Internal Organization of Membranes: Vesicles, Membrane Networks and GTP-binding Proteins, J. Cell Science 107:753-763, 1994.
Gekle and Silbernagl, Comparison of the Buffer Capacity of Endocytotic Vesicles, Lysosomes and Cytoplasm in Cells Derived from the Proximal Tubule of the Kidney, Pflugers Arch--Eur. J. Physiol. 429:452-454, 1995.
AlphaGene Inc.
Pak John
LandOfFree
Treatment of pulmonary conditions associated with insufficient s does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of pulmonary conditions associated with insufficient s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of pulmonary conditions associated with insufficient s will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1448249